Worldwide Plant Variety Application Filings Reached Record Highs in 2021 Despite a global economic downturn and the COVID-19 pandemic, a report recently published by the World Intellectual Property Organization (WIPO) reveals there was sustained growth in worldwide IP filings in 2021. From 2020, patent filings grew by 3.6%, trademark filings grew by 5.5%, and plant variety applications grew by a staggering 12%. This double digit […] Read Post →
Solicitor General Urges Supreme Court to Deny Cert in Amgen Antibody Patenting Case In an amicus brief for the United States Government released September 21, 2022, the Solicitor General advises the Supreme Court to deny Amgen Inc.’s petition for a writ of certiorari in the Amgen v. Sanofi case. If the Supreme Court follows the Government’s suggestion, it could mean a swift end for the controversial antibody patenting […] Read Post →
USPTO Extends Cancer Immunotherapy Pilot Program The United States Patent and Trademark Office recently issued a notice extending the Cancer Immunotherapy Pilot Program (AKA “Patents 4 Patients”) until September 30, 2022. The program was first implemented in 2016 as part of the $1 billion National Cancer Moonshot initiative and allows for fast-track review of cancer immunotherapy-related patent applications without the need […] Read Post →
USPTO Issues Final Rule Amending Rules of Practice For Biological Sequence Listings On May 20th, the United States Patent and Trademark Office published a Final Rule amending the rules of practice associated with disclosures of nucleotide and amino acid sequences in patent applications. The new standards, applicable to all patent applications filed on or after July 1, 2022, will bring the USPTO rules of practice into conformity […] Read Post →